Balance about balanz

Peritoneal Dialysis International

Volumn 32, Issue 5, 2012, Pages 493-496

  Blake, Peter G ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CREATININE; GLUCOSE DEGRADATION PRODUCT; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

ANURIA; ARTICLE; BACTERIAL PERITONITIS; BIOCOMPATIBILITY; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; DIALYSIS MEMBRANE; DISEASE SEVERITY; FOLLOW UP; HEMODIALYSIS; HOSPITALIZATION; HOST RESISTANCE; HUMAN; IMMUNITY; KIDNEY FUNCTION; NEUTRAL PH; NONHUMAN; PATIENT CARE; PERITONEAL DIALYSIS; PH; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS; STUDY DESIGN; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRAFILTRATION; UREMIA; URINE VOLUME; WEIGHT GAIN;

BIOCOMPATIBLE MATERIALS; DIALYSIS SOLUTIONS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS;

EID: 84866441380     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00225     Document Type: Article

References (18)

1. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, et al. on behalf of the balANZ Trial Investigators. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012; 23:1097-107.
2. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, et al. on behalf of the balANZ Trial Investigators. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol Dial Transplant 2012; [Epub ahead of print].
3. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MWY, et al. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Perit Dial Int 2012;32:497-506.
4. Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, et al. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998; 53:1061-7.
5. Hoff CM. In vitro biocompatibility performance of Physioneal. Kidney Int 2003; 88:S57-74.
6. Tranæus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000; 20:516-23.
7. Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008; 73:200-6.
8. Srivastava S, Hildebrand S, Fan SL. Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival. Kidney Int 2011; 80:986-91.
9. Pajek J, Kveder R, Bren A, Gucek A, Bucar M, Skoberne A, et al. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study. Nephrol Dial Transplant 2009; 24:1617-25.
10. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
11. Szeto CC, Chow KM, Lam CW, Leung CB, Kwan BC, Chung KY, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products-a 1-year randomized control trial. Nephrol Dial Transplant 2007; 22:552-9.
12. Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, et al. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int 2008; 28:174-82.
13. Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, et al. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study. Nephrol Dial Transplant 2009; 24:2899-908.
14. Weiss L, Stegmayr B, Malmsten G, Tejde M, Hadimeri H, Siegert CE, et al. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 2009; 29:647-55.
15. Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, et al. on behalf of the DIUREST Study Group. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant 2010; 25:2288-96.
16. Himmele R, Jensen L, Fenn D, Ho CH, Sawin DA, Diaz-Buxo JA. A new neutral-pH low-GDP peritoneal dialysis fluid. Perit Dial Int 2012; 32:444-52.
17. Davies SJ. Preserving residual renal function in peritoneal dialysis: volume or biocompatibility? Nephrol Dial Transplant 2009; 24:2620-2.
18. Li PK, Law MC, Chow KM, Chan WK, Szeto CC, Cheng YL, et al. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study. Am J Kidney Dis 2002; 40: 373-80.